Nasdaq · Healthcare
ELUTIA INC. (ELUT)
As-reported financials and recent SEC filings for ELUTIA INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$12.3M
Net income
$53.4M
Net margin
—
Diluted EPS
$0.87
ROE
192.9%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $12.3M | $14.5M | $24.7M | $23.8M | $47.4M |
| Gross profit | $6.6M | $6.7M | $11.1M | $11.6M | $19.0M |
| Operating income | $-26.9M | $-30.7M | $-30.5M | $-35.2M | $-23.0M |
| Net income | $53.4M | $-53.9M | $-37.7M | $-32.9M | $-24.8M |
| Diluted EPS | $0.87 | $-1.86 | $-2.07 | $-2.38 | $-2.38 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →8-K2026-06-16
View on EDGAR →42026-06-15
View on EDGAR →42026-06-15
View on EDGAR →42026-06-15
View on EDGAR →42026-06-15
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →Largest Healthcare peers
Go deeper on ELUT
Search ELUTIA INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.